# A Study of APL-10456-Vaccine

> **NCT07399132** · EARLY_PHASE1 · RECRUITING · sponsor: **Apollo Therapeutics Ltd** · enrollment: 144 (estimated)

## Conditions studied

- Rhinovirus

## Interventions

- **DRUG:** APL-10456-Vaccine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07399132
- **Lead sponsor:** Apollo Therapeutics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-16
- **Primary completion:** 2026-08-02
- **Final completion:** 2027-10-21
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07399132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07399132, "A Study of APL-10456-Vaccine". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07399132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*